"Coagulopathy of COVID-19: A Pragmatic Randomized Controlled Trial of Therapeutic Anticoagulation versus Standard Care as a Rapid Response to the COVID-19 Pandemic ( RAPID COVID COAG) "

drug protocol number
RC20/403
drug sponsor
KAIMRC
drug study
TINZAPARIN SODIUM
drug trial site
King Abdulaziz Medical City NG (Riyadh)
drug status
Completed
drug phase